SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

FNMA and FMCC are seeing intense volatility driven by speculation around potential GSE reform and government exit strategies, further fueled by high-profile endorsements from investors like Bill Ackman and Michael Burry. While the community remains deeply polarized between bullish long-term holders eyeing potential 10x gains and bearish traders skeptical of political timelines, buying interest has picked up significantly as investors monitor for news out of Washington.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is trending as investors digest a mixed earnings report that highlighted a pivot away from the Chinese market and the acceleration of a government-backed domestic magnet supply chain. The community is actively debating the long-term potential of the firm's '10X' facility and its strategic partnerships with major tech and defense entities, while some traders closely monitor the stock's volatility in response to broader geopolitical tensions.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is experiencing intense volatility as investors weigh strong quarterly revenue growth and aggressive expansion via recent acquisitions against concerns over dilution and persistent profitability challenges. The stock remains a battleground for retail traders, with the community actively debating whether the current price represents a tactical entry opportunity or an overvalued bubble susceptible to a sharp reversal.

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Phreesia Inc

Phreesia shares are reeling after the company lowered its fiscal 2027 revenue outlook, triggering significant investor disappointment and community concerns regarding the firm's growth trajectory. The stock is facing heavy downward pressure as traders debate whether the current selloff represents a deep-value opportunity or a sign of broader struggles within the SaaS sector.

Maul Coin

Maul Coin is generating significant retail buzz as a community-driven project, with supporters actively coordinating to push the token toward trending status and seeking improved visibility on trading platforms. The conversation is dominated by early investors urging others to hold through market volatility while comparing the token's potential to other viral meme coins.

Freddie Mac engages in the provision of housing finance system solutions. It operates through the Single-Family and Multifamily segments. The Single-Family segment is involved in purchase, securitization, and guarantee of single-family loans, investments, and management of single-family mortgage credit risk and market risk. The Multifamily segment focuses on purchase, securitization, and guarantee of multifamily loans, investments, securities, and management of multifamily mortgage credit risk and market risk. The company was founded on July 24, 1970 and is headquartered in McLean, VA.

Federal Home Loan Mortgage Corp

Freddie Mac

Freddie Mac (FMCC) and Fannie Mae are trending as investors speculate on a potential path out of government conservatorship, fueled by high-profile endorsements from Bill Ackman and Michael Burry. The community is heavily focused on the prospect of a major relisting on the NYSE, with active discussions debating whether the current market movement represents a fundamental rerating or a high-stakes political trade on future administration policy.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors weigh strong oncology pipeline progress against ongoing concerns regarding high debt levels, patent cliffs, and lukewarm results from its recent weight-loss drug trials. While the community is actively debating the stock's long-term growth potential and dividend stability, current sentiment remains split between those chasing income and those skeptical of the company's aggressive M&A strategy.

Progress Software Corp. engages in the provision of products that develop and deploy mission-critical business applications. Its products and solutions include Chef, Corticon, DataDirect, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity & WhatsUp Gold. The company was founded by Joseph Wright Alsop, Clyde Kessel, and Charles Arthur Ziering in 1981 and is headquartered in Burlington, MA.

Progress Software Corp.

Progress Software is trending as investors weigh strong earnings performance against concerns over Q4 guidance and the integration costs of the recently acquired ShareFile business unit. The community is actively debating the stock's long-term valuation and future growth prospects while navigating heightened volatility surrounding its latest financial results.

NextNav, Inc. engages in development of positioning, navigation, and timing solutions. Its products include NextNav Pinnacle, NextNav 3D, and NextNav TerraPoiNT. The company was founded by Ganesh Pattabiraman and Arun Raghupathy in May 2021 and is headquartered in Reston, VA.

NextNav Inc

NextNav is currently trending as investors monitor regulatory developments for a potential Notice of Proposed Rulemaking (NPRM) regarding its 900 MHz spectrum assets. Community discussion is heavily focused on interpreting recent FCC agenda leaks and technical filings, with many market participants viewing any price weakness as an accumulation opportunity while anticipating a shift in terrestrial PNT (Positioning, Navigation, and Timing) infrastructure.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending following a dramatic management overhaul that saw the removal of CEO Peter Greenleaf and key executives, with board chair Kevin Tang assuming the CEO role while electing to receive no compensation. Investors are actively debating the implications of this shift, with many interpreting the move as a long-awaited catalyst to accelerate a potential acquisition or strategic sale after years of frustration with the company's communication and valuation performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and...

PepGen, Inc. (NASDAQ:PEPG) Short Interest Up 26.1% in March

PepGen, Inc. (NASDAQ:PEPG - Get Free Report) was the target of a significant increase in short interest during the month of March. As of March 13th, there was short interest totaling 3,347,565 shares, an increase of 26.1% from the February 26th total of 2,654,341 shares. Currently, 5.1% of the...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG...

PepGen, Inc. (NASDAQ:PEPG) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of PepGen, Inc. (NASDAQ:PEPG - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the six research firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation and five have given a b...

Boxer Capital Management LLC Invests $1.16 Million in PepGen, Inc. $PEPG

Boxer Capital Management LLC bought a new stake in PepGen, Inc. (NASDAQ:PEPG - Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought 250,000 shares of...

Commodore Capital LP Invests $10.89 Million in PepGen, Inc. $PEPG

Commodore Capital LP bought a new position in shares of PepGen, Inc. (NASDAQ:PEPG - Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund bought...

Research Analysts Offer Predictions for PepGen Q1 Earnings

PepGen, Inc. (NASDAQ:PEPG - Free Report) - Analysts at HC Wainwright increased their Q1 2026 EPS estimates for PepGen in a research note issued to investors on Thursday, March 5th. HC Wainwright...

FDA Places Partial Hold On PepGen's Myotonic Dystrophy Drug Trial

PepGen (PEPG) shifts focus to DM1 but faces a fresh FDA roadblock. Clinical data, analyst ratings, and technical support levels inside.read more...

PepGen (NASDAQ:PEPG) Posts Earnings Results, Beats Expectations By $0.11 EPS

PepGen (NASDAQ:PEPG - Get Free Report) announced its earnings results on Wednesday. The company reported ($0.27) earnings per share for the quarter, beating the consensus estimate of ($0.38) by $0.11...

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.

PepGen Inc

Patrick OShaughnessy - @patrick_oshag on X

Citrini - @Citrini7 on X

Bucco Capital - @buccocapital on X

Joe Weisenthal - @TheStalwart on X

The must-watch individual or show that brings entertainment to finance. This award celebrates the content you look forward to daily - bringing a sharp market edge to engaging discussions. 

Current Price	$4.23
Prev Close	$4.52
Open	$4.54
Dividend Yield	0.00%
50-Day Moving Average	$5.59
Beta	1.32
Avg. Volume	631,394.61
PE Ratio	-1.87

52-Week High	$7.80
52-Week Low	$0.8801
Market Capitalization	$312.4M
EPS (Annual)	-$2.12
Price to Book	2.11
Revenue Per Employee	$0.00

PEPG
PepGen Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PEPG News

PEPGPepGen Inc